Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction

Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction

US Patent 7507531 · Granted Mar 24, 2009

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genetic susceptibility variants associated with cardiovascular disease2017
Genetic markers for risk management of atrial fibrillation, atrial flutter, and 2014
Methods of diagnosing susceptibility to myocardial infarction and screening for 2012
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of trea2010